The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Prediction of acute myeloid leukaemia risk in healthy individuals
Open accessAbstract
The incidence of acute myeloid leukaemia (AML) increases with age and mortality exceeds 90% when diagnosed after age 65. Most cases arise without any detectable early symptoms and patients usually present with the acute complications of bone marrow failure 1. The onset of such de novo AML cases is typically preceded by the accumulation of somatic mutations in preleukaemic haematopoietic stem and progenitor cells (HSPCs) that undergo clonal expansion 2,3. However, recurrent AML mutations also accumulate in HSPCs during ageing of healthy individuals who do not develop AML, a phenomenon referred to as age-related clonal haematopoiesis (ARCH)4-8. Here we use deep sequencing to analyse genes that are recurrently mutated in AML to distinguish between individuals who have a high risk of developing AML and those with benign ARCH. We analysed peripheral blood cells from 95 individuals that were obtained on average 6.3 years before AML diagnosis (pre-AML group), together with 414 unselected age- and gender-matched individuals (control group). Pre-AML cases were distinct from controls and had more mutations per sample, higher variant allele frequencies, indicating greater clonal expansion, and showed enrichment of mutations in specific genes. Genetic parameters were used to derive a model that accurately predicted AML-free survival; this model was validated in an independent cohort of 29 pre-AML cases and 262 controls. Because AML is rare, we also developed an AML predictive model using a large electronic health record database that identified individuals at greater risk. Collectively our findings provide proof-of-concept that it is possible to discriminate ARCH from pre-AML many years before malignant transformation. This could in future enable earlier detection and monitoring, and may help to inform intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, progression to hematological malignancies depends on the type and complexity of mutations in CHIP.2,5,6”
From Aging drives Tet2 +/− clonal hematopoiesis via IL-1 signaling (2023) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CH-associated variants of the epigenetic writers and erasers Dnmt3a and Tet2, respectively, that affect the HSPC methylome have been shown to alter functions of monocyte-derived tissue M F and promote cardiovascular pathologies 31-34 .”
From Clonal hematopoiesis-associated motoric deficits caused by monocyte-derived microglia accumulating in aging mice (2025) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CH prominently involves variants of epigenetic regulatory genes, such as DNMT3A and TET2, which constitute an increased risk for hematologic malignancies, cardiovascular events and stroke 34,45,70,71 .”
From Clonal hematopoiesis-associated motoric deficits caused by monocyte-derived microglia accumulating in aging mice (2025) · cites this paper as [34]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Clone size, which is approximated by the variant allele fraction (VAF), has previously been shown to be an important predictor of risk for blood cancer1,17 and cardiovascular outcomes8,9.”
From Clonal hematopoiesis is associated with protection from Alzheimer’s disease (2023) · cites this paper as [17]
The cited source says what the claim attributes to it.
In the citing paper
“CH prominently involves variants of epigenetic regulatory genes, such as DNMT3A and TET2, which constitute an increased risk for hematologic malignancies, cardiovascular events and stroke 34,45,70,71 .”
From Clonal hematopoiesis-associated motoric deficits caused by monocyte-derived microglia accumulating in aging mice (2025) · cites this paper as [34]
In the citing paper
“Both groups found that individuals with antecedent clonal hematopoiesis were at ~3 to 5-fold increased risk for developing AML in the subsequent years (Fig. 3A).”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [71]
In the citing paper
“The effect of specific gene variants on various outcomes may be quite different, as has been found in AML 71.”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
BEDTools: a flexible suite of utilities for comparing genomic features
Quinlan, A. R., & Hall, I. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq033 · Cited by 27,437
Fast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
Arber, D. A., Orazi, A., Hasserjian, R., Thiele, J., Borowitz, M. J., Le Beau, M. M., Bloomfield, C. D., Cazzola, M., & Vardiman, J. W. (2016) · Blood · doi:10.1182/blood-2016-03-643544 · Cited by 10,119
Modeling Survival Data: Extending the Cox Model
Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencingPreprint
Koboldt, D. C., Zhang, Q., Larson, D. E., Shen, D., McLellan, M. D., Lin, L., Miller, C. A., Mardis, E. R., Ding, L., & Wilson, R. K. (2012) · Genome Research · doi:10.1101/gr.129684.111 · Cited by 4,954
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Genomic classification and prognosis in acute myeloid leukemia
Papaemmanuil, E., Gerstung, M., Bullinger, L., Gaidzik, V. I., Paschka, P., Roberts, N. D., Potter, N. E., Heuser, M., Thol, F., Bolli, N., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1516192 · Cited by 4,350
Self-citationClonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Cited by
Sorted by citations
Items 201–300 of 847
Clonal hematopoiesis and its impact on the aging osteo-hematopoietic niche
Winter, S., Götze, K. S. S., Hecker, J. S., Metzeler, K. H., Guezguez, B., Woods, K., Medyouf, H., Schäffer, A., Schmitz, M., Wehner, R., et al. (2024) · Leukemia · doi:10.1038/s41375-024-02226-6 · Cited by 46
TP53 Mutations in Acute Leukemias and Myelodysplastic Syndromes: Insights and Treatment Updates
Santini, V., Stahl, M. F., & Sallman, D. A. (2024) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_432650 · Cited by 52
TP53 ‐Mutated Myeloid Neoplasms: 2024 Update on Diagnosis, Risk‐Stratification, and Management
Shah, M. V., Arber, D. A., & Hiwase, D. (2025) · American Journal of Hematology · doi:10.1002/ajh.27655 · Cited by 43
Clonal hematopoiesis and preleukemia—Genetics, biology, and clinical implications
Hartmann, L., & Metzeler, K. H. (2019) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22756 · Cited by 42
Stiehl, T., Wang, W., Lutz, C., & Marciniak-Czochra, A. K. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0283 · Cited by 39
Immunotherapy in Hematologic Malignancies: Emerging Therapies and Novel Approaches
Noh, J., Seo, H., Lee, J., & Jung, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218000 · Cited by 40
Insights into the molecular profiles of adult and paediatric acute myeloid leukaemia
Aung, M. M. K., Mills, M. L., Bittencourt‐Silvestre, J., & Keeshan, K. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12899 · Cited by 42
PHF6 Mutations in Hematologic Malignancies
Kurzer, J. H., & Weinberg, O. K. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.704471 · Cited by 41
Shin, T., Zhou, Y., Chen, S., Cordes, S., Grice, M. Z., Fan, X., Lee, B., Aljanahi, A. A., Hong, S. G., Vaughan, K. L., et al. (2022) · Blood · doi:10.1182/blood.2021014875 · Cited by 39
Zheng, Z., Curtis, J. H., Yao, Y., Gasparik, J., Anantharaj, V. G., Zhao, L., West, M., & Riemer, N. (2020) · Earth and Space Science · doi:10.1029/2020ea001500 · Cited by 38
Saygin, C., Zhang, P., Stauber, J., Aldoss, I. T., Sperling, A. S., Weeks, L. D., Luskin, M. R., Knepper, T. C., Wanjari, P., Wang, P., et al. (2023) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-23-0106 · Cited by 37
Castelli, G., Pelosi, E., & Testa, U. (2019) · Cancers · doi:10.3390/cancers11020260 · Cited by 39
Discovery through clinical sequencing in oncology
Donoghue, M. T. A., Schram, A. M., Hyman, D. M., & Taylor, B. S. (2020) · Nature Cancer · doi:10.1038/s43018-020-0100-0 · Cited by 38
Systematic analysis of exonic germline and postzygotic de novo mutations in bipolar disorder
Nishioka, M., Kazuno, A., Nakamura, T., Sakai, N., Hayama, T., Fujii, K., Matsuo, K., Komori, A., Ishiwata, M., Watanabe, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23453-w · Cited by 38
Kim, R., Bergugnat, H., Larcher, L., Duchmann, M., Passet, M., Gachet, S., Cuccuini, W., Lafage‐Pochitaloff, M., Pastoret, C., Grardel, N., et al. (2023) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-22-0154 · Cited by 39
Liu, Z. S., Sinha, S., Bannister, M. H., Song, A., Arriaga-Gomez, E. A., McKeeken, A. J., Bonner, E. A., Hanson, B. K., Sarchi, M., Takashima, K., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-3239 · Cited by 38
The paradox of mutations and cancer
Chanock, S. J. (2018) · Science · doi:10.1126/science.aav5697 · Cited by 37
Bewersdorf, J. P., Ardasheva, A., Podoltsev, N. A., Singh, A., Biancon, G., Halene, S., & Zeidan, A. M. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.100587 · Cited by 37
Kong, F., He, H., Bai, H., Yang, F., Ma, M., Gu, N., & Zhang, Y. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.03.022 · Cited by 36
Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma Precursors
Schroers‐Martin, J. G., Soo, J., Brisou, G., Scherer, F., Kurtz, D. M., Sworder, B. J., Khodadoust, M. S., Jin, M. C., Bru, A., Liu, C. L., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-0111 · Cited by 43
Clonal hematopoiesis in older patients with breast cancer receiving chemotherapy
Mayerhofer, C., Sedrak, M. S., Hopkins, J. O., Li, T., Tayob, N., Faggen, M. G., Sinclair, N. F., Chen, W. Y., Parsons, H. A., Mayer, E. L., et al. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad065 · Cited by 38
IL-1 in aging and pathologies of hematopoietic stem cells
Caiado, F., & Manz, M. G. (2024) · Blood · doi:10.1182/blood.2023023105 · Cited by 40
Clonal hematopoiesis and cardiovascular disease: deciphering interconnections
Stein, A., Metzeler, K. H., Kubasch, A. S., Rommel, K., Desch, S., Buttner, P. G., Rosołowski, M., Cross, M. A., Platzbecker, U., & Thiele, H. (2022) · Basic Research in Cardiology · doi:10.1007/s00395-022-00969-w · Cited by 40
Updates on Old and Weary Haematopoiesis
Konieczny, J., & Arranz, L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092567 · Cited by 34
Steensma, D. P. (2018) · Blood · doi:10.1182/blood-2018-06-860882 · Cited by 34
Contribution of clonal hematopoiesis to adult-onset hemophagocytic lymphohistiocytosis
Miller, P. G., Sperling, A. S., Gibson, C. J., Viswanathan, K., Castellano, C. A., McConkey, M. E., Ceremsak, J. J., Taylor, M. S., Birndt, S., Perner, F., et al. (2020) · Blood · doi:10.1182/blood.2020008206 · Cited by 34
Todisco, G., Creignou, M., Gallì, A., Guglielmelli, P., Rumi, E., Roncador, M., Rizzo, E., Nannya, Y., Pietra, D., Elena, C., et al. (2020) · Leukemia · doi:10.1038/s41375-020-01106-z · Cited by 35
Dissecting Clonal Hematopoiesis in Tissues of Patients with Classic Hodgkin Lymphoma
Venanzi, A., Marra, A., Schiavoni, G., Milner, S. G., Limongello, R., Santi, A., Pettirossi, V., Ultimo, S., Tasselli, L., Pucciarini, A., et al. (2021) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-20-0203 · Cited by 33
Recurrent deletions in clonal hematopoiesis are driven by microhomology-mediated end joining
Feldman, T., Bercovich, A., Moskovitz, Y., Chapal-Ilani, N., Mitchell, A., Medeiros, J. J. F., Biezuner, T., Kaushansky, N., Minden, M. D., Gupta, V. K., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22803-y · Cited by 34
Differential diagnosis of bone marrow failure syndromes guided by machine learning
Gutierrez‐Rodrigues, F., Munger, E., Ma, X., Groarke, E. M., Tang, Y., Patel, B. A., Catto, L. F. B., Clé, D. V., Niewisch, M. R., Alves‐Paiva, R. M., et al. (2022) · Blood · doi:10.1182/blood.2022017518 · Cited by 37
Mitchell, K., & Steidl, U. G. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036251 · Cited by 37
Kim, J.-S., Trzebanski, S., Shin, S.-H., Schori, L., Frumer Friedman, G. R., Ilani, N. C., Kadam, A., Vicario, R., Aust, O., Bugaeva, P., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115609 · Cited by 33
Williams, L. S., Williams, K. M., Gillis, N., Bolton, K. L., Damm, F., Deuitch, N. T., Farhadfar, N., Gergis, U. S., Keel, S., Michelis, F. V., et al. (2023) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2023.10.018 · Cited by 35
The Ups and Downs of STAT Inhibition in Acute Myeloid Leukemia
Moser, B., Edtmayer, S., Witalisz‐Siepracka, A., & Stoiber, D. (2021) · Biomedicines · doi:10.3390/biomedicines9081051 · Cited by 35
Marongiu, F., & DeGregori, J. V. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13275 · Cited by 38
Clonal Hematopoiesis and risk of Acute Myeloid Leukemia
Desai, P. M., Hassane, D. C., & Roboz, G. J. (2019) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2019.05.007 · Cited by 36
Rockne, R. C., Branciamore, S., Qi, J., Frankhouser, D. E., O’Meally, D., Hua, W.-K., Cook, G., Carnahan, E., Zhang, L., Marom, A., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0354 · Cited by 32
Chromosomal Instability in Acute Myeloid Leukemia
Lisboa, M. D. O., Brofman, P. R. S., Schmid-Braz, A. T., Pozzo, A. R., & Mai, S. (2021) · Cancers · doi:10.3390/cancers13112655 · Cited by 33
Computational analysis of peripheral blood smears detects disease-associated cytomorphologies
de Almeida, J. G., Gudgin, E. J., Besser, M. W., Dunn, W. G., Cooper, J. L., Haferlach, T., Vassiliou, G. S., & Gerstung, M. (2023) · Nature Communications · doi:10.1038/s41467-023-39676-y · Cited by 31
Saunderson, E. A., Encabo, H. H., Devis, J., Rouault‐Pierre, K., Piganeau, M., Bell, C. G., Gribben, J. G., Bonnet, D. A., & Ficz, G. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2300224120 · Cited by 34
Kumar, R., Shah, S. R., & Stiehl, T. (2024) · Applied Mathematical Modelling · doi:10.1016/j.apm.2024.01.048 · Cited by 45
TP53-mutated acute myeloid leukemia: how can we improve outcomes?
Sallman, D. A., & Stahl, M. F. (2024) · Blood · doi:10.1182/blood.2024024245 · Cited by 32
Insights into clonal hematopoiesis and its relation to cancer risk
Mitchell, S. R., Gopakumar, J., & Jaiswal, S. (2021) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2020.12.004 · Cited by 31
Anti-CD117 immunotherapy to eliminate hematopoietic and leukemia stem cells
Russkamp, N. F., Myburgh, R., Kiefer, J. D., Neri, D., & Manz, M. G. (2021) · Experimental Hematology · doi:10.1016/j.exphem.2021.01.003 · Cited by 32
Role of TET dioxygenases in the regulation of both normal and pathological hematopoiesis
Joshi, K., Zhang, L., Breslin, P., Kini, A. R., & Zhang, J. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02496-x · Cited by 31
Clonal Hematopoiesis: Updates and Implications at the Solid Tumor-Immune Interface
Buttigieg, M. M., & Rauh, M. J. (2023) · JCO Precision Oncology · doi:10.1200/po.23.00132 · Cited by 30
Jung, A. W., Holm, P. C., Gaurav, K., Hjaltelin, J. X., Placido, D., Mortensen, L. H., Birney, E., Brunak, S., & Gerstung, M. (2024) · The Lancet Digital Health · doi:10.1016/s2589-7500(24)00062-1 · Cited by 29
Are we witnessing the start of a therapeutic revolution in acute myeloid leukemia?
Bewersdorf, J. P., Stahl, M. F., & Zeidan, A. M. (2019) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2018.1546854 · Cited by 30
Bhat, K. S., Kim, H., Alam, A., Ko, M., An, J., & Lim, S. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202101193 · Cited by 30
Jawad, M. D., Afkhami, M., Ding, Y., Zhang, X., Li, P., Young, K., Xu, M. L., Cui, W., Zhao, Y., Halene, S., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.849376 · Cited by 29
Dong, Q., Song, N., Qin, N., Chen, C., Li, Z., Sun, X., Easton, J. B., Mulder, H. L., Plyler, E. M., Neale, G. A. M., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01038-6 · Cited by 28
Risk factors for clonal hematopoiesis of indeterminate potential and mosaic chromosomal alterations
Jakubek, Y. A., Reiner, A. P., & Honigberg, M. C. (2022) · Translational research · doi:10.1016/j.trsl.2022.11.009 · Cited by 30
Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia
Sirenko, M., Lee, S., Sun, Z., Chaligne, R., Loghavi, S., Asimomitis, G., Brierley, C. K., Bernard, E., Cai, S. F., Myers, R. M., et al. (2025) · Cell Stem Cell · doi:10.1016/j.stem.2025.04.012 · Cited by 28
Therapeutic Targeting of RNA Splicing in Cancer
Bonner, E. A., & Lee, S. C.-W. (2023) · Genes · doi:10.3390/genes14071378 · Cited by 30
Hematopoietic-specific heterozygous loss of Dnmt3a exacerbates colitis-associated colon cancer
Feng, Y., Yuan, Q., Newsome, R. C., Robinson, T. M., Bowman, R. L., Zuniga, A. N., Hall, K. N., Bernsten, C. M., Shabashvili, D. E., Krajcik, K. I., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20230011 · Cited by 30
The lifelong natural history of clonal hematopoiesis and its links to myeloid neoplasia
Fabre, M. A., & Vassiliou, G. S. (2023) · Blood · doi:10.1182/blood.2023019964 · Cited by 32
Xu, Q., & Yu, L. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000685 · Cited by 29
Implications of Clonal Hematopoiesis for Precision Oncology
Miller, P. G., & Steensma, D. P. (2020) · JCO Precision Oncology · doi:10.1200/po.20.00144 · Cited by 30
Peres, L. C., Colin, C., Teng, M., Dutil, J., Alugubelli, R. R., DeAvila, G., Teer, J. K., Du, D., Mo, Q., Siegel, E. M., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2021006652 · Cited by 29
Clonal Hematopoiesis in Hospitalized Elderly Patients With COVID‐19
Hameister, E., Stolz, S. M., Fuhrer, Y., Thienemann, F., Schaer, D. J., Nemeth, J., Schuepbach, R. A., Goede, J. S., Reinhart, S., Schmidt, A. E., et al. (2020) · HemaSphere · doi:10.1097/hs9.0000000000000453 · Cited by 28
Hashimoto, M., Saito, Y., Nakagawa, R., Ogahara, I., Takagi, S., Takata, S., Amitani, H., Endo, M., Yuki, H., Ramilowski, J. A., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00177-w · Cited by 29
Incidence and prognosis of clonal hematopoiesis in patients with chronic idiopathic neutropenia
Tsaknakis, G., Gallì, A., Papadakis, S., Kanellou, P., Elena, C., Todisco, G., Bono, E. B., Rizzo, E., Molteni, E., Fragiadaki, I., et al. (2021) · Blood · doi:10.1182/blood.2021010815 · Cited by 28
Targeting TP53-Mutated Acute Myeloid Leukemia: Research and Clinical Developments
Granowicz, E. M., & Jonas, B. A. (2022) · OncoTargets and Therapy · doi:10.2147/ott.s265637 · Cited by 31
Gondek, L. P., Sheehan, V., & Fitzhugh, C. D. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11113160 · Cited by 27
Distinct landscape and clinical implications of therapy-related clonal hematopoiesis
Takahashi, K., Nakada, D., & Goodell, M. A. (2024) · Journal of Clinical Investigation · doi:10.1172/jci180069 · Cited by 32
Khalife‐Hachem, S., Saleh, K., Pasquier, F., Willekens, C., Tarabay, A., Antoun, L., Grinda, T., Castilla‐Llorente, C., Duchmann, M., Quivoron, C., et al. (2021) · HemaSphere · doi:10.1097/hs9.0000000000000632 · Cited by 27
Tahri, S., Mouhieddine, T. H., Redd, R. A., Lampe, L. M., Nillson, K., El‐Khoury, H., Su, N. K., Nassar, A. H., Adib, E., Bindra, G. S., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021004926 · Cited by 30
Nowakowska, M. K., Kim, T., Thompson, M. T., Bolton, K. L., Deswal, A., Lin, S. H., Scheet, P. A., Wehner, M. R., & Nead, K. T. (2022) · American Journal of Hematology · doi:10.1002/ajh.26465 · Cited by 28
Clonal Hematopoiesis and therapy related MDS/AML
Desai, P. M., & Roboz, G. J. (2019) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2019.02.006 · Cited by 28
Hou, S., Liu, J., & Zhu, Y. (2025) · Cell investigation. · doi:10.1016/j.clnves.2025.100007 · Cited by 26
Sellar, R. S., Jaiswal, S., & Ebert, B. L. (2018) · Nature Medicine · doi:10.1038/s41591-018-0114-7 · Cited by 27
Biological implications of clonal hematopoiesis
Luis, T. C., Wilkinson, A. C., Beerman, I., Jaiswal, S., & Shlush, L. I. (2019) · Experimental Hematology · doi:10.1016/j.exphem.2019.08.004 · Cited by 29
Lackraj, T., Barouch, S. B., Medeiros, J. J. F., Pedersen, S., Danesh, A., Bakhtiari, M., Hong, M., Tong, K. I., Joynt, J., Arruda, A., et al. (2022) · American Journal of Hematology · doi:10.1002/ajh.26726 · Cited by 26
Somatic mutations and T-cell clonality in patients with immunodeficiency
Savola, P., Martelius, T., Kankainen, M., Huuhtanen, J., Lundgren, S., Koski, Y., Eldfors, S., Kelkka, T., Keränen, M. A. I., Ellonen, P., et al. (2019) · Haematologica · doi:10.3324/haematol.2019.220889 · Cited by 25
The Role of Somatic Mutations in Acute Myeloid Leukemia PathogenesisPreprint
Kishtagari, A., & Levine, R. L. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a034975 · Cited by 26
Germline genetic variation impacts clonal hematopoiesis landscape and progression to malignancy
Liu, J., Tran, D., Xue, L., Wiley, B. J., Vlasschaert, C., Watson, C. J., MacGregor, H. A. J., Zong, X., Chan, I. C. C., Das, I., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02250-x · Cited by 28
Ribosome biogenesis is a downstream effector of the oncogenic U2AF1-S34F mutation
Akef, A., McGraw, K. R., Cappell, S. D., & Larson, D. R. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000920 · Cited by 25
Oster, H. S., Crouch, S., Smith, A. G., Yu, G., Shrkihe, B. A., Baruch, S., Kolomansky, A., Ben‐Ezra, J. M., Naor, S., Fenaux, P., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020004055 · Cited by 25
Yoshimi, A., Trippett, T. M., Zhang, N., Chen, X., Penson, A. V., Arcila, M. E., Pichardo, J. D., Baik, J., Sigler, A. M., Harada, H., et al. (2020) · Oncogene · doi:10.1038/s41388-020-1204-9 · Cited by 25
Identification of a human hematopoietic stem cell subset that retains memory of inflammatory stressPreprint
Zeng, A. G. X., Nagree, M. S., Jakobsen, N. A., Shah, S., Murison, A., Cheong, J.-G., Turkalj, S., Lim, I., Jin, L.-Q., Araújo, J., et al. (2023) · bioRxiv · doi:10.1101/2023.09.11.557271 · Cited by 15
Germline Predisposition in Hematologic Malignancies: Testing, Management, and Implications
Godley, L. A., Dinardo, C. D., & Bolton, K. L. (2024) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_432218 · Cited by 25
Cytokine-induced killer cells: new insights for therapy of hematologic malignancies
Sevari, F. G., Mehdizadeh, A., Abbasi, K., Hejazian, S. S., & Raeisi, M. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03869-z · Cited by 25
Ullrich, F., Bröckelmann, P. J., Turki, A. T., Khan, A., Chiru, E.-D., Vetter, M. H. F., von Tresckow, B., Wirth, R., Córdoba, R., Ortiz‐Maldonado, V., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-009462 · Cited by 25
Rhee, J., Bolton, K. L., Gupta, D., Weeks, L. D., Bick, A. G., Tall, A. R., Walsh, K. X., Fuster, J. J., & Natarajan, P. (2026) · Circulation · doi:10.1161/cir.0000000000001404 · Cited by 31
Clonal Hematopoiesis of Indeterminate Potential
Boettcher, S., & Ebert, B. L. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.79.3588 · Cited by 25
CD123 as a Therapeutic Target Against Malignant Stem Cells
Sugita, M., & Guzmán, M. L. (2020) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2020.01.004 · Cited by 24
Lauber, C., Correia, N., Trumpp, A., Rieger, M. A., Dolnik, A., Bullinger, L., Roeder, I., & Seifert, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-69691-8 · Cited by 24
The clinical implications of clonal hematopoiesis in hematopoietic cell transplantation
Nawas, M. T., Schetelig, J., Damm, F., Levine, R. L., Perales, M., Giralt, S., van den Brink, M. R. M., Arcila, M. E., Zehir, A., Papaemmanuil, E., et al. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100744 · Cited by 23
Isoform-specific and signaling-dependent propagation of acute myeloid leukemia by Wilms tumor 1
Potluri, S., Assi, S. A., Chin, P. S., Coleman, D. J. L., Pickin, A., Moriya, S., Seki, N., Heidenreich, O. T., Cockerill, P. N., & Bonifer, C. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109010 · Cited by 21
Genetics of Myelodysplastic Syndromes
Saygin, C., & Godley, L. A. (2021) · Cancers · doi:10.3390/cancers13143380 · Cited by 24
Clonal hematopoiesis in men living with HIV and association with subclinical atherosclerosis
Wang, S., Paşca, S., Post, W. S., Langan, S. J., Pallavajjalla, A., Haley, L. M., Gocke, C. D., Budoff, M. J., Haberlen, S., Brown, T. T., et al. (2022) · AIDS · doi:10.1097/qad.0000000000003280 · Cited by 24
Epigenetic reversal of hematopoietic stem cell aging in Phf6-knockout mice
Wendorff, A. A., Quinn, S. A., Álvarez, S., Brown, J. A., Biswas, M., Gunning, T. S., Palomero, T., & Ferrando, A. A. (2022) · Nature Aging · doi:10.1038/s43587-022-00304-x · Cited by 24
Updates in molecular genetics of acute myeloid leukemia
Kurzer, J. H., & Weinberg, O. K. (2023) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2023.04.002 · Cited by 28
Evolutionary trajectory of leukemic clones and its clinical implications
Tuval, A., & Shlush, L. I. (2019) · Haematologica · doi:10.3324/haematol.2018.195289 · Cited by 28
Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome
Tovy, A., Rosas, C., Gaikwad, A. S., Medrano, G., Zhang, L., Reyes, J. M., Huang, Y., Arakawa, T., Kurtz, K. J., Conneely, S. E., et al. (2021) · Haematologica · doi:10.3324/haematol.2021.278990 · Cited by 27
Aging and comprehensive molecular profiling in acute myeloid leukemia
Li, J., Cheng, W., Lin, X., Wen, L., Wang, K., Zhu, Y., Zhu, H., Chen, X., Zhang, Y., Yin, W., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2319366121 · Cited by 30
Hoermann, G., Greiner, G., Griesmacher, A., & Valent, P. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030094 · Cited by 23
Roadmap on plasticity and epigenetics in cancer
Foo, J., Basanta, D., Rockne, R. C., Strelez, C., Shah, C. A., Ghaffarian, K., Mumenthaler, S. M., Mitchell, K., Lathia, J. D., Frankhouser, D. E., et al. (2022) · Physical Biology · doi:10.1088/1478-3975/ac4ee2 · Cited by 24
Discovery of U2AF1 neoantigens in myeloid neoplasms
Biernacki, M. A., Lok, J., Black, R. G., Foster, K. A., Cummings, C. C., Woodward, K. B., Monahan, T. M., Oehler, V. G., Stirewalt, D. L., Wu, D., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007490 · Cited by 24
Amorós-Pérez, M., & Fuster, J. J. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.02.008 · Cited by 24
Metadata
- Authors
- Abelson, S., Collord, G., Ng, S. W. K., Weissbrod, O., Mendelson Cohen, N., Niemeyer, E., Barda, N., Zuzarte, P. C., Heisler, L., Sundaravadanam, Y., Luben, R., Hayat, S., Wang, T. T., Zhao, Z., Cirlan, I., Pugh, T. J., Soave, D., Ng, K., Latimer, C., Hardy, C., Raine, K., Jones, D., Hoult, D., Britten, A., McPherson, J. D., Johansson, M., Mbabaali, F., Eagles, J., Miller, J. K., Pasternack, D., Timms, L., Krzyzanowski, P., Awadalla, P., Costa, R., Segal, E., Bratman, S. V., Beer, P., Behjati, S., Martincorena, I., Wang, J. C. Y., Bowles, K. M., Quirós, J. R., Karakatsani, A., La Vecchia, C., Trichopoulou, A., Salamanca-Fernández, E., Huerta, J. M., Barricarte, A., Travis, R. C., Tumino, R., Masala, G., Boeing, H., Panico, S., Kaaks, R., Krämer, A., Sieri, S., Riboli, E., Vineis, P., Foll, M., McKay, J., Polidoro, S., Sala, N., Khaw, K.-T., Vermeulen, R., Campbell, P. J., Papaemmanuil, E., Minden, M. D., Tanay, A., Balicer, R. D., Wareham, N. J., Gerstung, M., Dick, J. E., Brennan, P., Vassiliou, G. S., & Shlush, L. I.
- Affiliations
- University Health Network (CA)
- University of Cambridge (GB)
- University of Toronto (CA)
- Weizmann Institute of Science (IL)
- Clalit Health Services (IL)
- Ontario Institute for Cancer Research (CA)
- Wellcome Sanger Institute (GB)
- Centre international de recherche sur le cancer (FR)
- European Bioinformatics Institute (GB)
- University of East Anglia (GB)
- Gobierno del Principado de Asturias (ES)
- National and Kapodistrian University of Athens (GR)
- Hellenic Health Foundation (GR)
- Instituto Murciano de Investigación Biosanitaria (ES)
- Instituto de Salud Pública de Navarra (ES)
- University of Oxford (GB)
- Istituto per lo Studio e la Prevenzione Oncologica (IT)
- German Institute of Human Nutrition (DE)
- Federico II University Hospital (IT)
- German Cancer Research Center (DE)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- Imperial College London (GB)
- Italian institute for Genomic Medicine (IT)
- Institut d'Investigació Biomédica de Bellvitge (ES)
- Utrecht University (NL)
- Memorial Sloan Kettering Cancer Center (US)
- World Health Organization (CH)
- Wellcome/MRC Cambridge Stem Cell Institute (GB)
- Corresponding author
- Gerstung, Moritz
- Dick, John E.
- Brennan, Paul
- Vassiliou, George S.
- Shlush, Liran I.
- ORCID
- Abelson, Sagi
- Collord, Grace
- Ng, Stanley W. K.
- Weissbrod, Omer
- Barda, Noam
- Zuzarte, Philip C.
- Heisler, Lawrence
- Sundaravadanam, Yogi
- Luben, Robert
- Hayat, Shabina
- Zhao, Zhen
- Cirlan, Iulia
- Pugh, Trevor J.
- Soave, David
- Ng, Karen
- Latimer, Calli
- Raine, Keiran
- Jones, David
- Britten, Abigail
- McPherson, John D.
- Johansson, Mattias
- Eagles, Jenna
- Miller, Jessica K.
- Krzyzanowski, Paul
- Awadalla, Philip
- Costa, Rui
- Segal, Eran
- Bratman, Scott V.
- Beer, Philip
- Behjati, Sam
- Wang, Jean C. Y.
- Bowles, Kristian M.
- Karakatsani, Anna
- Trichopoulou, Antonia
- Huerta, José M.
- Barricarte, Aurelio
- Travis, Ruth C.
- Tumino, Rosario
- Masala, Giovanna
- Boeing, Heiner
- Panico, Salvatore
- Kaaks, Rudolf
- Krämer, Alwin
- Sieri, Sabina
- Vineis, Paolo
- Foll, Matthieu
- McKay, James
- Polidoro, Silvia
- Sala, Núria
- Khaw, Kay-Tee
- Vermeulen, Roel
- Campbell, Peter J.
- Papaemmanuil, Elli
- Minden, Mark D.
- Tanay, Amos
- Balicer, Ran D.
- Wareham, Nicholas J.
- Gerstung, Moritz
- Dick, John E.
- Brennan, Paul
- Vassiliou, George S.
- Shlush, Liran I.
- Venue
- Nature
- Published
- 2018-07
- Volume
- 559
- Issue
- 7714
- Pages
- 400-404
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC6485381
- OpenAlex
- W2830196912
- Cited by
- 850
- References
- 49
- Citations by year
- 2026: 52 · 2025: 83 · 2024: 95 · 2023: 116 · 2022: 122 · 2021: 116 · 2020: 143 · 2019: 91 · 2018: 29
- FWCI
- 67.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, public-domain)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, public-domain)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- eScholarship (California Digital Library) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- Apollo
- Funders
- World Health Organization
- Leukemia and Lymphoma Society
- Wellcome Trust (WT 098051, WT095663MA)
- Cancer Research UK (23015, 14136, 16491, 21777)
- National Institute for Health and Care Research (NF-SI-0512-10114, NF-SI-0512-10135, NF-SI-0617-10149)
- Generalitat de Catalunya
- Associazione Italiana per la Ricerca sul Cancro
- Clalit Health Services
- Abisch-Frenkel-Stiftung
- Hellenic Health Foundation
- Medical Research Council (MC_UU_12015/1, MC_PC_13048, MC_PC_12009, MR/N003284/1)
- Agència de Gestió d'Ajuts Universitaris i de Recerca
- Instituto de Salud Carlos III (RD12/0036/0018)
- European Regional Development Fund
- National Cancer Institute (P30CA008748)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Keywords
- acute myeloid leukemia, somatic mutations, clonal expansion, variant allele frequency
- MeSH terms
- Adult, Age Factors, Aged, Female, Health, Humans, Male, Middle Aged, Models, Genetic, Mutation, Leukemia, Myeloid, Acute, Prevalence, Mutagenesis, Disease Progression, Risk Assessment, Genetic Predisposition to Disease, Electronic Health Records
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
